Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2014-10-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Pathogenesis of Hepatitis C Virus Vertical Transmission
NCT01921400
Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population
NCT00894257
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers
NCT04366973
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
NCT01705717
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
NCT05975216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HCV pregnant women
HCV chronically infected pregnant women, with a positive HCV RNA during pregnancy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a positive HCV RNA
* who gave birth in the Maternity Department, Lariboisiere Hospital, Paris, France
Exclusion Criteria
* acute HCV infection during pregnancy (previous negative HCV test during pregnancy)
* MTCT not to be tested (early child death for instance)
9 Months
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Lariboisière
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephane Mouly, MD PhD
Professor at University Paris VII Denis Diderot, physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre O SELLIER, M.D., Ph.D
Role: PRINCIPAL_INVESTIGATOR
Hopital Lariboisiere
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Lariboisiere
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Liver005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.